ACAD vs EOG · P/E 15, rev $957.8M vs P/E 11, rev $22.63B
ACADIA Pharmaceuticals Inc (ACAD) versus EOG Resources Inc (EOG) — a side-by-side from cached financials, not a winner call.
ACADIA Pharmaceuticals Inc (ACAD) is a biotechnology company listed on US.
EOG Resources Inc (EOG) is a oil & gas e&p company listed on US.
Latest reported ACAD revenue for 2024-12-31 was $957.8M. Net income was $226.5M. Revenue was up 314.6% from 2023-12-31 to 2024-12-31. ACAD currently screens at market cap $3.51B and trailing P/E 15.3.
Latest reported EOG revenue for 2025-12-31 was $22.63B. Net income was $4.98B. Revenue was down 4.5% from 2024-12-31 to 2025-12-31. EOG currently screens at market cap $66.44B and trailing P/E 11.3.
ACAD currently screens at market cap $3.51B and trailing P/E 15.3. EOG currently screens at market cap $66.44B and trailing P/E 11.3.
Not investment advice. Open the ACAD and EOG stock pages for the full models.
Not investment advice.